Ep190: Neil Kumar on Building a Rare Disease Drug Company
The Long Run with Luke Timmerman
00:00
Diversification, focus, and risk correlation
Neil discusses how diverse Mendelian targets reduce correlated risk and attract different investor types.
Play episode from 23:36
Transcript
